Ryan M. Teague

2.2k total citations
38 papers, 1.7k citations indexed

About

Ryan M. Teague is a scholar working on Immunology, Oncology and Molecular Biology. According to data from OpenAlex, Ryan M. Teague has authored 38 papers receiving a total of 1.7k indexed citations (citations by other indexed papers that have themselves been cited), including 28 papers in Immunology, 21 papers in Oncology and 6 papers in Molecular Biology. Recurrent topics in Ryan M. Teague's work include Immune Cell Function and Interaction (20 papers), CAR-T cell therapy research (14 papers) and Immunotherapy and Immune Responses (13 papers). Ryan M. Teague is often cited by papers focused on Immune Cell Function and Interaction (20 papers), CAR-T cell therapy research (14 papers) and Immunotherapy and Immune Responses (13 papers). Ryan M. Teague collaborates with scholars based in United States, Spain and Canada. Ryan M. Teague's co-authors include Huda Y. Zoghbi, Paolo Moretti, Justin Kline, J. Adriaan Bouwknecht, Richard Paylor, Richard Atkinson, Jonathan M. Levenson, Barbara Antalffy, Fortunato Battaglia and J. David Sweatt and has published in prestigious journals such as Journal of Clinical Investigation, Nature Medicine and Nature Communications.

In The Last Decade

Ryan M. Teague

37 papers receiving 1.7k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ryan M. Teague United States 19 757 600 571 499 383 38 1.7k
Alessio Delogu United Kingdom 17 794 1.0× 179 0.3× 775 1.4× 247 0.5× 223 0.6× 33 2.0k
Vinodh Narayanan United States 25 399 0.5× 749 1.2× 1.2k 2.0× 94 0.2× 398 1.0× 67 2.3k
Willy M. Nillesen Netherlands 23 300 0.4× 1.3k 2.1× 1.3k 2.2× 119 0.2× 156 0.4× 42 2.2k
Ariya D. Lapan United States 6 795 1.1× 182 0.3× 569 1.0× 167 0.3× 96 0.3× 6 1.5k
Roderick T. Bronson United States 7 315 0.4× 815 1.4× 1.6k 2.8× 380 0.8× 115 0.3× 7 3.0k
Susan Moore United Kingdom 20 204 0.3× 716 1.2× 873 1.5× 92 0.2× 224 0.6× 30 2.0k
Maria Lia Palomba United States 25 243 0.3× 174 0.3× 495 0.9× 963 1.9× 70 0.2× 84 2.1k
Yo Niida Japan 21 338 0.4× 334 0.6× 453 0.8× 244 0.5× 155 0.4× 93 1.6k
Tatsuya Kishino Japan 27 318 0.4× 1.9k 3.2× 2.4k 4.2× 175 0.4× 192 0.5× 64 3.3k
Yuta Katayama Japan 15 181 0.2× 228 0.4× 448 0.8× 157 0.3× 169 0.4× 96 1.0k

Countries citing papers authored by Ryan M. Teague

Since Specialization
Citations

This map shows the geographic impact of Ryan M. Teague's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ryan M. Teague with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ryan M. Teague more than expected).

Fields of papers citing papers by Ryan M. Teague

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ryan M. Teague. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ryan M. Teague. The network helps show where Ryan M. Teague may publish in the future.

Co-authorship network of co-authors of Ryan M. Teague

This figure shows the co-authorship network connecting the top 25 collaborators of Ryan M. Teague. A scholar is included among the top collaborators of Ryan M. Teague based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ryan M. Teague. Ryan M. Teague is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Donlin, Maureen J., et al.. (2024). T-Cell Expression of CXCL13 is Associated with Immunotherapy Response in a Sex-Dependent Manner in Patients with Lung Cancer. Cancer Immunology Research. 12(8). 956–963. 4 indexed citations
4.
Hoft, Stella G., et al.. (2022). Single-cell analysis of peripheral CD8+ T cell responses in patients receiving checkpoint blockade immunotherapy for cancer. Cancer Immunology Immunotherapy. 72(2). 397–408. 7 indexed citations
5.
Griffett, Kristine, Thomas P. Burris, Kelly D. Pyles, et al.. (2020). Fructose Promotes Cytoprotection in Melanoma Tumors and Resistance to Immunotherapy. Cancer Immunology Research. 9(2). 227–238. 29 indexed citations
6.
Donlin, Maureen J., Eddy C. Hsueh, Theresa Schwartz, et al.. (2020). Oxidized Lipoproteins Promote Resistance to Cancer Immunotherapy Independent of Patient Obesity. Cancer Immunology Research. 9(2). 214–226. 26 indexed citations
7.
Bockerstett, Kevin A., Christine Petersen, Eric L. Ford, et al.. (2020). Interleukin 27 Protects From Gastric Atrophy and Metaplasia During Chronic Autoimmune Gastritis. Cellular and Molecular Gastroenterology and Hepatology. 10(3). 561–579. 23 indexed citations
8.
Berrien-Elliott, Melissa M., et al.. (2016). Rescue of Tolerant CD8+ T Cells during Cancer Immunotherapy with IL2:Antibody Complexes. Cancer Immunology Research. 4(12). 1016–1026. 13 indexed citations
9.
Berrien-Elliott, Melissa M., et al.. (2014). Checkpoint Blockade Immunotherapy Relies on T-bet but Not Eomes to Induce Effector Function in Tumor-Infiltrating CD8+ T Cells. Cancer Immunology Research. 3(2). 116–124. 28 indexed citations
10.
11.
Zhang, Long, Xiufen Chen, Xiao Liu, et al.. (2013). CD40 ligation reverses T cell tolerance in acute myeloid leukemia. Journal of Clinical Investigation. 123(5). 1999–2010. 58 indexed citations
12.
Berrien-Elliott, Melissa M., Stephanie R. Jackson, Hideo Yagita∥, et al.. (2012). Durable Adoptive Immunotherapy for Leukemia Produced by Manipulation of Multiple Regulatory Pathways of CD8+ T-Cell Tolerance. Cancer Research. 73(2). 605–616. 38 indexed citations
13.
Teague, Ryan M., Philip D. Greenberg, Carla Fowler, et al.. (2008). Peripheral CD8+ T Cell Tolerance to Self-Proteins Is Regulated Proximally at the T Cell Receptor. Immunity. 28(5). 662–674. 39 indexed citations
14.
Moretti, Paolo, Jonathan M. Levenson, Fortunato Battaglia, et al.. (2006). Learning and Memory and Synaptic Plasticity Are Impaired in a Mouse Model of Rett Syndrome. Journal of Neuroscience. 26(1). 319–327. 427 indexed citations
15.
Greenberg, Philip D., William Ho, Matthias Wölfl, et al.. (2006). Overcoming obstacles to the generation of T cells for tumor therapy. 6. 13. 1 indexed citations
16.
Teague, Ryan M., Blythe Sather, Jilian A. Sacks, et al.. (2006). Interleukin-15 rescues tolerant CD8+ T cells for use in adoptive immunotherapy of established tumors. Nature Medicine. 12(3). 335–341. 186 indexed citations
17.
Ho, William, et al.. (2005). Isolating tumor-reactive T cells and making them work in tumor therapy. 5. 25. 1 indexed citations
18.
Teague, Ryan M., et al.. (2004). MIP-1 α Induces Differential MAP Kinase Activation and I κ B Gene Expression in Human B Lymphocytes. Journal of Interferon & Cytokine Research. 24(7). 403–410. 4 indexed citations
19.
Teague, Ryan M., et al.. (2001). MIP-1α Induces Activation of Phosphatidylinositol-3 Kinase That Associates with Pyk-2 and Is Necessary for B-Cell Migration. Experimental Cell Research. 268(1). 77–83. 18 indexed citations
20.
Teague, Ryan M., et al.. (2000). MIP-1α Induces Binding of Nuclear Factors to the κB DNA Element in Human B Cells. PubMed. 4(1). 15–19. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026